MOLECULAR BASIS OF INHERITED DEAFNESS
遗传性耳聋的分子基础
基本信息
- 批准号:6379335
- 负责人:
- 金额:$ 21.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-07-01 至 2003-06-30
- 项目状态:已结题
- 来源:
- 关键词:angiogenesis inhibitors animal genetic material tag antisense nucleic acid clinical research complementary DNA congenital deafness ear hair cell enzyme activity enzyme induction /repression gene expression gene mutation human genetic material tag human subject isozymes laboratory mouse male myosins protein structure function sex linked trait tissue /cell culture
项目摘要
In this proposal we outline studies on three genes for inherited
deafness: those encoding Norrie (Norrie disease), myosin-VIIa
(Usher 1B and the shaker-1 mouse), and myosin-VIIb (a candidate
for the twirler and shaker-2 mouse mutants). The Norrie studies
continue work done in the first two years of t his grant, while the
myosin studies initiate two new programs.
Norrie disease is a rare X-linked syndromic deafness, with
congenital blindness and progressive hearing loss. We have
cloned the gene defective in this disease; it encodes a small,
secreted protein (norrin) that my be a growth factor. The
pathology in some vagrants of the disease suggest that a defective
norrin allows excessive growth of blood vessels - that it isnorally
an angiogenesis inhibitor. We propose several methods to test this
hypothesis, and propose to initiate or continue audiometric and
histological studies of both humans and mice with this defective
gene.
Usher 1B presents with congenial deafness and absence of
vestibular function, and progressive loss of vision. It is the most
common genetic deafness in humans. The gene defective encodes
myosinVIIa, a protein that connects and moves other proteins on
action. We have closed human myosin-VIIa, and have used
antibodies to locate it in auditory receptor cells with electron
microscopy. We will test a specific hypotheses that myosin-VIIA
is involved in maintaining cohesion of the mechanosensitive cilia,
by using a mutant mouse, shaker-1, that has defective myosin-VIIa
and by using gene transfers to disrupt myosin-VIIa in normal
mice.
There is evidence that other myosin-VII isoforms exist in the
cochlea, and that they may also cause deafness when defective.
We have closed fragments of the genes and have compared their
chromosomal location to genetic deafness in mice. We propose to
clone these other isoforms, and to test them as candidate deafness
genes.
在本提案中,我们概述了对遗传性的三个基因的研究
耳聋:编码 Norrie(诺里病)、肌球蛋白-VIIa 的基因
(Usher 1B 和 shaker-1 小鼠)和肌球蛋白-VIIb(候选
对于 twirler 和 shaker-2 小鼠突变体)。 诺里研究
继续该拨款的前两年所做的工作,同时
肌球蛋白研究启动了两个新项目。
诺里病是一种罕见的 X 连锁耳聋综合征,
先天性失明和进行性听力损失。 我们有
克隆了这种疾病的缺陷基因;它编码一个小,
分泌的蛋白质(诺林)是一种生长因子。 这
一些疾病流浪者的病理学表明,有缺陷的
Norrin 会导致血管过度生长 - 这实际上是正常的
血管生成抑制剂。 我们提出了几种方法来测试这一点
假设,并建议启动或继续听力测试和
对具有这种缺陷的人类和小鼠进行的组织学研究
基因。
Usher 1B 患有先天性耳聋和失神
前庭功能和进行性视力丧失。 这是最
人类常见的遗传性耳聋。 基因缺陷编码
肌球蛋白VIIa,一种连接并移动其他蛋白质的蛋白质
行动。 我们已经封闭了人肌球蛋白-VIIa,并使用了
抗体用电子将其定位在听觉受体细胞中
显微镜。 我们将测试肌球蛋白-VIIA 的具体假设
参与维持机械敏感纤毛的凝聚力,
使用肌球蛋白-VIIa 有缺陷的突变小鼠 shaker-1
并通过使用基因转移来破坏正常细胞中的肌球蛋白-VIIa
老鼠。
有证据表明,其他肌球蛋白 VII 亚型存在于
耳蜗,当它们有缺陷时也可能导致耳聋。
我们已经关闭了基因片段并比较了它们
小鼠遗传性耳聋的染色体位置。 我们建议
克隆这些其他亚型,并测试它们作为候选耳聋
基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID P COREY其他文献
DAVID P COREY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID P COREY', 18)}}的其他基金
Development of Gene Therapy for Hereditary Deafness using Rational Protein Engineering
利用合理蛋白质工程开发遗传性耳聋基因疗法
- 批准号:
10649587 - 财政年份:2022
- 资助金额:
$ 21.19万 - 项目类别: